section name header

Pronunciation ⬇

loe-PER-a-mide audio

Indications ⬆ ⬇

REMS

Action ⬆ ⬇

Therapeutic Effects:

Pharmacokinetics ⬆ ⬇

Absorption: Not well absorbed following oral administration.

Distribution: Unknown. Does not cross the blood-brain barrier.

Protein Binding: 97%.

Metabolism/Excretion: Metabolized partially by the liver, undergoes enterohepatic recirculation; 30% eliminated in the feces. Minimal excretion in the urine.

Half-life: 10.8 hr.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

CV: CARDIAC ARREST, QT INTERVAL PROLONGATION, TORSADES DE POINTES, VENTRICULAR ARRHYTHMIAS, syncope.

GI: constipation, abdominal pain/distention/discomfort, dry mouth, nausea, vomiting.

Neuro: drowsiness, dizziness.

Misc: allergic reactions.

Interactions ⬆ ⬇

Drug-Drug:

Drug-Natural Products:

Route/Dosage ⬆ ⬇

Acute and Chronic Diarrhea

Acute Diarrhea

Chronic Diarrhea

Implementation ⬆ ⬇

US Brand Names ⬆ ⬇

Imodium A-D

Canadian Brand Names ⬆ ⬇

Imodium

Classifications ⬆ ⬇

Therapeutic Classification: antidiarrheals

Availability ⬆ ⬇

(Generic available)

Time/Action Profile ⬆ ⬇

(relief of diarrhea)

ROUTEONSETPEAKDURATION
PO1 hr2.5–5 hr10 hr

Assessment ⬆ ⬇

Pot. Nursing Diagnoses ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

Code ⬆

NDC Code*